Abstract

    Open Access Case Report Article ID: AHR-3-113

    Constipation during Entecavir treatment in Chronic Hepatitis B patients: Two Cases Reports

    Meng-Lan Wang, Dong-Mei Zhang and En-Qiang Chen*

    Entecavir (ETV) is an oral nucleoside analog inhibitor of hepatitis B virus (HBV) DNA polymerase, which is widely used in patients with chronic hepatitis B (CHB). Despite the excellent safety data of this agent, the adverse events of headache, diarrhea, nausea and vomiting are recorded in the drug instruction of ETV. Here we report two CHB patients with ETV-associated constipation in whom symptom fully disappeared following ETV withdrawal.

    Keywords: Entecavir; Chronic hepatitis B; Constipation; Adverse event

    Published on: May 29, 2017 Pages: 27-28

    Full Text PDF Full Text HTML DOI: 10.17352/ahr.000013
    CrossMark Publons Harvard Library HOLLIS Search IT Semantic Scholar Get Citation Base Search Scilit OAI-PMH ResearchGate Academic Microsoft GrowKudos Universite de Paris UW Libraries SJSU King Library SJSU King Library NUS Library McGill DET KGL BIBLiOTEK JCU Discovery Universidad De Lima WorldCat VU on WorldCat

    Indexing/Archiving

    Pinterest on AHR